Bryan Margulies

Bryan Margulies has a diverse work experience in the field of biopharmaceuticals, orthopedic surgery, and stem cell research. Bryan is currently serving as the Chief Scientific Officer and Co-founder of Zetagen Therapeutics, a private biopharmaceutical company focused on innovative treatments for metastatic bone cancers. Before that, they worked as an Assistant Professor at the State University of New York Upstate Medical University, where they studied mesenchymal stem cell biology and was a member of the SUNY Cancer Research Institute. Prior to that, they were a Post Doctoral Fellow at the University of Pennsylvania, where they oversaw stem cell and bone growth projects and studied Wnt and BMP signaling in stem cells. Early in their career, they were a NIH NRSA Fellow at The National Institutes of Health, where they developed an animal model for pediatric sarcoma and researched the effects of radiation therapy on bone growth.

Bryan Margulies has a diverse education history. Bryan started their academic journey by obtaining a Bachelor of Science (B.S.) degree in Bioengineering from Syracuse University in 1998. Following this, they pursued a Master of Science (M.S.) degree in Bioengineering, also at Syracuse University, from 1998 to 2002.

In 1999, Bryan attended Cornell University, where they focused on Animal Pathology, Histomorphology, and Surgery. Although it is not specified, it can be assumed that they pursued a specific field of study within animal pathology during this period, although they did not receive a specific degree from Cornell University.

Continuing their academic pursuits, Bryan Margulies pursued a Ph.D. in Bioengineering at Syracuse University from 2002 to 2007. Bryan'sresearch and coursework during this time further developed their expertise in the field.

To complement their Ph.D., Bryan engaged in Post Doctoral Training at the University of Pennsylvania from 2007 to 2009. During this period, they specialized in the field of Bone Stem Cell Biology.

Overall, Bryan Margulies' educational background includes a Bachelor's degree in Bioengineering, a Master's degree in Bioengineering, a Ph.D. in Bioengineering, and additional specialized training in Bone Stem Cell Biology.